apparently, judging from recent SITC data, they're not bad at running clinical trials either. I know most retail hate the guy, but when Adam Feuerstein has joined the bandwagon, that's when it starts to get interesting; at least you can say the drug is legitimate. The guy has the best nano-cap biotech bullshit detector I have ever seen. Not always right, of course, but he cuts through a lot of bs. In the case of ONCS, at least he has given it the benefit of the doubt, and that's saying something, coming from him.
Market Data 
Markets 
AI
